Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Compound Library

Anti-Cancer Approved Drug Library

Catalog No. L2110

During the past decades, we have witnessed many landmark discoveries and successes in cancer research and therapy,however, cancer is still a major health problem for human beings, and it often physically and emotionally brings pains and difficulties to those living with it. Cancer cells remain undifferentiated (continue to divide, causing more damage, and invading new tissue), lack normal cell signaling responses (loss of contact inhibition and evasion of programmed cell death), contain abnormal changes (genetic abnormalities) in chromatin, have altered energy metabolism, and induce vascularization (ensure a steady supply of oxygen and nutrients). We carefully select 1779 approved anti-cancer drugs based on published literatures and database to form this collection that can be used as positive controls in biological cancer investigation and cancer correlation study.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Resource Download
Library compound info
Excel
PDF
Contact us for more batch information

Catalog No. L2110

Anti-Cancer Approved Drug Library
sizeIn stock
  • 1 mg
  • 30 μL x 10 mM (in DMSO)
  • 50 μL x 10 mM (in DMSO)
  • 100 μL x 10 mM (in DMSO)
  • 250 μL x 10 mM (in DMSO)
Inquiry & Custom

Top Publication Citing
Use of TargetMol Products

Cite scientific literature on TargetMol products

View More

Product Description Product Description

  • A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
  • These FDA, EMA, or NMPA approved anti-cancer drugs have annotated bioactivity, safety, and bioavailability;
  • Effective tool for cancer research and drug repurposing screening;
  • Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc., in lung cancer, breast cancer, leukemia, lymphoma, etc.
  • Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
  • Structurally diverse, medicinally active, and cell permeable;
  • NMR and HPLC validated to ensure high purity and quality;

Packaging And Storage | TargetMol Packaging And Storage

  • Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
  • Shipped with blue ice

Library Customization | TargetMol Library Customization

Compound Library | TargetMol
Targetmol Compound Libraries
can be highly customized!
Inquiry & Custom

Library Customization | TargetMol Library Composition

Autophagy
Apoptosis
Adrenergic Receptor
5-HT Receptor
Endogenous Metabolite
Antibacterial
COX
Antibiotic
Dopamine Receptor
Histamine Receptor
Sodium Channel
DNA/RNA Synthesis
Potassium Channel
Calcium Channel
AChR
Parasite
Glucocorticoid Receptor
P450
HIV Protease
Antifungal
NF-κB
Reactive Oxygen Species
Estrogen/progestogen Receptor
Ferroptosis
EGFR
VEGFR
GABA Receptor
c-Kit
Mitophagy
Topoisomerase
PPAR
Nucleoside Antimetabolite/Analog
PDGFR
SARS-CoV
Dehydrogenase
Estrogen Receptor/ERR
Prostaglandin Receptor
Influenza Virus
PDE
Serotonin Transporter
Microtubule Associated
Norepinephrine
ATPase
Proton pump
iGluR
Androgen Receptor
FLT
DNA Alkylator/Crosslinker
RAAS
HSV
JAK
FGFR
HDAC
Bcr-Abl
Src
c-Met/HGFR
Adenosine Receptor
Virus Protease
Opioid Receptor
TRP/TRPV Channel
HBV
Tyrosine Kinases
Progesterone Receptor
GNRH Receptor
Raf
PKC
CDK
TNF
DHFR
MAO
NMDAR
ROS
SGLT
ALK
Retinoid Receptor
Carbonic Anhydrase
PARP
Antifolate
MRP
Drug Metabolite
P-gp
AChE
HMG-CoA Reductase
Reverse Transcriptase
HCV Protease
Phosphatase
Proteasome
Antifection
AMPK
c-RET
P2Y Receptor
PI3K
BTK
DNA Alkylation
MMP
GluR
Lipoxygenase
CaMK
mTOR
HIF/HIF Prolyl-Hydroxylase
Monoamine Oxidase
Chloride channel
NADPH
ABC
Monoamine Transporter
Guanylate cyclase
Trk receptor
MEK
CFTR
STAT
GPR
Phospholipase
TAM Receptor
Thrombin
HER
Transferase
Mitochondrial Metabolism
ERK
P2X Receptor
BCL
IL Receptor
Interleukin
Hedgehog/Smoothened
Aromatase
Neurokinin receptor
DNA Methyltransferase
S1P Receptor
Histone Methyltransferase
LPL Receptor
Glutathione Peroxidase
PKA
Caspase
ROCK
FXR
Vasopressin Receptor
DNA
Akt
TLR
Endothelin Receptor
ribosome
Nrf2
HIF
Ras
ROS Kinase
GSK-3
Melatonin Receptor
Amino Acids and Derivatives
p38 MAPK
Antioxidant
CaSR
Wnt/beta-catenin
Annexin A
Smo
DPP-4
Fatty Acid Synthase
PGE Synthase
HSP
GPCR19
Antiviral
IκB/IKK
Beta Amyloid
NO Synthase
Oxytocin Receptor
NOD
Sigma receptor
Tyrosinase
Integrin
Serine Protease
Serine/threonin kinase
UGT
Cysteine Protease
Leukotriene Receptor
Gamma-secretase
MT Receptor
Na-K-Cl cotransporter
CXCR
Xanthine Oxidase
TGF-beta/Smad
Free radical scavengers
Molecular Glues
Isocitrate Dehydrogenase (IDH)
PAK
IGF-1R
Aminopeptidase
GST
c-Fms
cholecystokinin
AhR
Ligand for E3 Ligase
Melanocortin Receptor
Hydroxylase
Adenosine deaminase
Syk
FAK
NOS
Monocarboxylate transporter
ROR
CRM1
Arginase
Reductase
Cell wall
CAT
Ligands for Target Protein for PROTAC
YAP
LTR
IFNAR
IRE1
LDL
DNA gyrase
Rho
Aryl Hydrocarbon Receptor
Hexokinase
Somatostatin
Aurora Kinase
Beta-Secretase
Decarboxylase
CCR
Lipid
MAPK
OAT
Ephrin Receptor
CGRP Receptor
Protease-activated Receptor
RSV
GHSR
PLK
Cannabinoid Receptor
Gap Junction Protein
NOD-like Receptor (NLR)
BACE
RAR/RXR 
JNK
TOPK
Thyroid hormone receptor(THR)
Mdm2
NPC1L1
Hydrogenase
Na+/Ca2+ Exchanger
Histone Demethylase
Lipase
Factor Xa
VDA
IAP
Adiponectin receptor
Hck
Liver X Receptor
Immunology/Inflammation related
CSF-1R
PAFR
MTH1
GRK
Glucagon Receptor
Bradykinin Receptor
Chk
cAMP
Thrombopoietin Receptor
Epigenetic Reader Domain
DUB
ATP Citrate Lyase
Glutathione reductase
Sirtuin
PROTAC Linker
FAAH
OX Receptor
PAD
ACK
Indoleamine 2,3-Dioxygenase (IDO)
GluCls
Pyroptosis
Neprilysin
PDK
Complement System
Platelet aggregation
NADPH-oxidase
S6 Kinase
p53
Imidazoline Receptor
PD-1/PD-L1

Keywords